Literature DB >> 30772177

Prevalence and Clinical Impact of Systemic Inflammatory Reaction After Cardiac Surgery.

Enrico Squiccimarro1, Cataldo Labriola2, Pietro Giorgio Malvindi3, Vito Margari3, Pietro Guida4, Giuseppe Visicchio3, Georgios Kounakis3, Antonella Favale2, Pierpaolo Dambruoso2, Giuseppe Mastrototaro3, Roberto Lorusso5, Domenico Paparella6.   

Abstract

OBJECTIVES: Cardiac surgery induces a systemic inflammatory reaction that has been associated with postoperative mortality and morbidity. Many studies have characterized this reaction through laboratory biomarkers while clinical studies generally are lacking. This study aimed to assess the incidence of postoperative systemic inflammation after cardiac surgery, and the association of postoperative systemic inflammation with preoperative patients' characteristics and postoperative outcomes.
DESIGN: Retrospective analysis of prospectively collected data. Analysis of the overall population and of propensity-matched subgroups.
SETTING: Cardiac surgery intensive care unit. PATIENTS: Adult patients who underwent cardiac surgery with cardiopulmonary bypass (CPB) between June 2016 and June 2017.
INTERVENTIONS: Mixed cardiac surgery operations on CPB.
MEASUREMENTS AND MAIN RESULTS: During the study period, 502 patients underwent cardiac surgery with CPB. One hundred forty-two patients (28.3%) fulfilled SIRS criteria at 24 hours. After performing a multivariate analysis to adjust for the procedure type and preoperative systemic inflammatory reaction syndrome (SIRS) parameters, the occurrence of SIRS was associated inversely with age and extracardiac arteriopathy, and it was associated positively with preoperative white blood cell count. Vasopressors were used more frequently in SIRS patients who further experienced longer mechanical ventilation time and length of stay in the intensive care unit (ICU). The incidence of a composite outcome including death, transient ischemic attack/stroke, renal replacement therapy, bleeding, postoperative intra-aortic balloon pump insertion, and a length of stay in ICU >96 hours was more frequent in SIRS-positive patients. There was no difference between overall and matched subgroups for in-hospital mortality.
CONCLUSION: In this retrospective study, the clinical signs of SIRS were detected in a substantial percentage of patients who underwent cardiac surgery. The postoperative SIRS criteria were associated with a more complicated postoperative course and higher postoperative morbidity.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SIRS; cardiac surgery; cardiopulmonary bypass; outcome; sepsis; systemic inflammatory syndrome

Mesh:

Year:  2019        PMID: 30772177     DOI: 10.1053/j.jvca.2019.01.043

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  15 in total

1.  Concomitant elevated serum levels of tenascin, MMP-9 and YKL-40, suggest ongoing remodeling of the heart up to 3 months after cardiac surgery after normalization of the revascularization markers.

Authors:  Da Liu; Danyal Ghani; Justin Wain; Wilson Y Szeto; Krzysztof Laudanski
Journal:  Eur J Med Res       Date:  2022-10-21       Impact factor: 4.981

2.  Effect of aortic cross-clamp time on late survival after isolated aortic valve replacement.

Authors:  Ben M Swinkels; Jurriën M Ten Berg; Johannes C Kelder; Freddy E Vermeulen; Wim Jan Van Boven; Bas A de Mol
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-22

3.  Epileptic seizure discharges in patients after open chamber cardiac surgery-a prospective prevalence pilot study using continuous electroencephalography.

Authors:  Marlene Tschernatsch; Martin Juenemann; Fouad Alhaidar; Jasmin El Shazly; Marius Butz; Marco Meyer; Tibo Gerriets; Markus Schönburg; Patrick Schramm
Journal:  Intensive Care Med       Date:  2020-05-13       Impact factor: 17.440

4.  The neutrophil-lymphocyte ratio is associated with postoperative mortality of cardiac surgery.

Authors:  Qixun Wang; Jinghang Li; Xiaowei Wang
Journal:  J Thorac Dis       Date:  2021-01       Impact factor: 2.895

Review 5.  Quantitative and Qualitative Platelet Derangements in Cardiac Surgery and Extracorporeal Life Support.

Authors:  Enrico Squiccimarro; Federica Jiritano; Giuseppe Filiberto Serraino; Hugo Ten Cate; Domenico Paparella; Roberto Lorusso
Journal:  J Clin Med       Date:  2021-02-06       Impact factor: 4.241

6.  Hemoperfusion with HA380 in acute type A aortic dissection patients undergoing aortic arch operation (HPAO): a randomized, controlled, double-blind clinical trial.

Authors:  Jing Yang; Dong Ji; Yue-Qian Zhu; Yun Ren; Xun Zhang; Hong-Yu Dai; Xu Sun; Yi Zhou; Zhi-Yuan Chen; Qing-Guo Li; Hao Yao
Journal:  Trials       Date:  2020-11-23       Impact factor: 2.279

7.  Plasma from patients undergoing coronary artery bypass graft surgery does not activate endothelial cells under shear stress in vitro.

Authors:  Sophie F Ellermann; Thomas W L Scheeren; Rianne M Jongman; Katja Nordhoff; Christiane L Schnabel; Grietje Molema; Gregor Theilmeier; Matijs Van Meurs
Journal:  Int J Crit Illn Inj Sci       Date:  2021-09-25

8.  Impact of Venoarterial Extracorporeal Membrane Oxygenation on Alkaline Phosphatase Metabolism after Cardiac Surgery.

Authors:  Thomas Poschner; Anne-Kristin Schaefer; Doris Hutschala; Georg Goliasch; Julia Riebandt; Klaus Distelmaier; Martin H Bernardi; Martin Andreas; Ruud Brands; Tandis Aref; Günther Laufer; Dominik Wiedemann
Journal:  Biomolecules       Date:  2021-05-17

9.  The Prognostic Significance of Neutrophil to Lymphocyte Ratio (NLR), Monocyte to Lymphocyte Ratio (MLR) and Platelet to Lymphocyte Ratio (PLR) on Long-Term Survival in Off-Pump Coronary Artery Bypass Grafting (OPCAB) Procedures.

Authors:  Tomasz Urbanowicz; Anna Olasińska-Wiśniewska; Michał Michalak; Michał Rodzki; Anna Witkowska; Ewa Straburzyńska-Migaj; Bartłomiej Perek; Marek Jemielity
Journal:  Biology (Basel)       Date:  2021-12-27

10.  Renal Safety of Hydroxyethyl starch 130/0.42 After Cardiac Surgery: A Retrospective Cohort Analysis.

Authors:  Benedict Morath; Andreas D Meid; Johannes Rickmann; Jasmin Soethoff; Markus Verch; Matthias Karck; Marcin Zaradzki
Journal:  Drug Saf       Date:  2021-09-26       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.